1. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1
   JIHUA NIE et al, 2015, Oncology Reports CrossRef
2. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1
   Junyong Zhao et al, 2019, Biomedicine & Pharmacotherapy CrossRef
3. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
   Sanjun Shi et al, 2014, Journal of Controlled Release CrossRef
4. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
   Eleonora A. Braga et al, 2019, Frontiers in Genetics CrossRef
5. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022, Urologic Cancers CrossRef
6. MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2/NOTCH1/CYCLIN D1 Coregulatory Network
   Cong Fan et al, 2016, Stem Cell Reports CrossRef
7. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer
   Siddharth Yadav et al, 2017, Urology CrossRef
8. Epigenetics in renal cell cancer: mechanisms and clinical applications
   Sophie C. Joosten et al, 2018, Nature Reviews Urology CrossRef
9. MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression
   QIANG LIN et al, 2015, Molecular Medicine Reports CrossRef
10. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells
    Wei Xie et al, 2017, Medical Science Monitor CrossRef
11. The Role of Noncoding RNAs in Genome Stability and Aging
    Igor Kovalchuk, 2018, Epigenetics of Aging and Longevity CrossRef
12. Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR-34a
    Ling Zhang et al, 2017, Oncology Reports CrossRef
13. miR-34a promotes bone regeneration in irradiated bone defects by enhancing osteoblastic differentiation of mesenchymal stromal cells in rats
    Huan Liu et al, 2019, Stem Cell Research & Therapy CrossRef
14. Notch signal integration in the vasculature during remodeling
    Bahman Rostama et al, 2014, Vascular Pharmacology CrossRef
15. The long non-coding RNA NEAT1 enhances epithelial-to-mesenchymal transition and chemoresistance via the miR-34a/c-Met axis in renal cell carcinoma
    Fei Liu et al, 2017, Oncotarget CrossRef
16. The effect of microRNA‐330 replacement on inhibition of growth and migration in renal cancer cells
    Jun Liu et al, 2022, Biotechnology and Applied Biochemistry CrossRef
17. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth
    Kefeng Wang et al, 2019, Cell Death & Disease CrossRef
18. The influence of miR-34a expression on stemness and cytotoxic susceptibility of breast cancer stem cells
    Hongyao Zhang et al, 2016, Cancer Biology & Therapy CrossRef
19. MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review)
    MING LI et al, 2015, Oncology Reports CrossRef
20. The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells
    Mohadeseh Hasanpourghadi et al, 2018, PeerJ CrossRef
21. MicroRNAs and lncRNAs in senescence: A re‐view
    Oliver Bischof et al, 2015, IUBMB Life CrossRef
22. Applications of noncoding RNAs in renal cancer patients
    Eman A. Toraih et al, 2022, Clinical Applications of Non-Coding RNAs in Cancer CrossRef
23. MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers
    Michal Fedorko et al, 2016, The International Journal of Biological Markers CrossRef